Status:
COMPLETED
SLMAP and EPO Genetic Polymorphism in Diabetic Retinopathy
Lead Sponsor:
Ain Shams University
Conditions:
Diabetic Retinopathy
Eligibility:
All Genders
30-60 years
Brief Summary
A case-control study to assess the association between the risk of diabetic retinopathy in Egyptians and genetic polymorphism of both EPO and SLMAP genes.
Detailed Description
Traditional environmental risk factors, such as glycemic control and duration of diabetes, failed to fully explain why some individuals remain protected while others progress to severe diabetic retino...
Eligibility Criteria
Inclusion
- Age \>30-60
- Type 2 DM
- Duration of diabetes from 5-10 years
- Egyptian patients
Exclusion
- Other ophthalmic diseases not related to diabetes
Key Trial Info
Start Date :
May 20 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2023
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT05344690
Start Date
May 20 2022
End Date
June 30 2023
Last Update
February 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University Hospitals
Cairo, Abbasseya, Egypt